Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Reading LevelReading Level
-
Content TypeContent Type
-
YearFrom:-To:
-
More FiltersMore FiltersItem TypeIs Full-Text AvailableSubjectPublisherSourceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
1,069
result(s) for
"Kruger, Peter"
Sort by:
First-Principles Calculation of Ligand Field Parameters for L-Edge Spectra of Transition Metal Sites of Arbitrary Symmetry
2023
Recently we have proposed a simple method for obtaining the parameters of a ligand field multiplet model for L-edge spectra calculations from density functional theory. Here we generalize the method to systems where the metal site has arbitrary point symmetry. The ligand field-induced splitting of the metal d-level becomes a hermitian matrix with cross-terms between the different d-orbitals. The anisotropy of the covalency is fully taken into account and it rescales the electron–electron interaction and the oscillator strength in an orbital-dependent way. We apply the method to polarization-dependent V L-edge spectra of vanadium pentoxide and obtain very good agreement with the experiment.
Journal Article
A new generation of magnetoencephalography: Room temperature measurements using optically-pumped magnetometers
by
Lim, Mark
,
Brookes, Matthew J.
,
Kruger, Peter
in
Auditory discrimination
,
Auditory pathways
,
Brain - physiology
2017
Advances in the field of quantum sensing mean that magnetic field sensors, operating at room temperature, are now able to achieve sensitivity similar to that of cryogenically cooled devices (SQUIDs). This means that room temperature magnetoencephalography (MEG), with a greatly increased flexibility of sensor placement can now be considered. Further, these new sensors can be placed directly on the scalp surface giving, theoretically, a large increase in the magnitude of the measured signal. Here, we present recordings made using a single optically-pumped magnetometer (OPM) in combination with a 3D-printed head-cast designed to accurately locate and orient the sensor relative to brain anatomy. Since our OPM is configured as a magnetometer it is highly sensitive to environmental interference. However, we show that this problem can be ameliorated via the use of simultaneous reference sensor recordings. Using median nerve stimulation, we show that the OPM can detect both evoked (phase-locked) and induced (non-phase-locked oscillatory) changes when placed over sensory cortex, with signals ~4 times larger than equivalent SQUID measurements. Using source modelling, we show that our system allows localisation of the evoked response to somatosensory cortex. Further, source-space modelling shows that, with 13 sequential OPM measurements, source-space signal-to-noise ratio (SNR) is comparable to that from a 271-channel SQUID system. Our results highlight the opportunity presented by OPMs to generate uncooled, potentially low-cost, high SNR MEG systems.
Journal Article
Berezinskii–Kosterlitz–Thouless crossover in a trapped atomic gas
by
Hadzibabic, Zoran
,
Cheneau, Marc
,
Krüger, Peter
in
Chemistry
,
Classical and quantum physics: mechanics and fields
,
Condensed Matter
2006
The plane truth
Physics in a two-dimensional environment is very different from what we observe in the three-dimensional world. If dimensionality is reduced, thermal fluctuations destroy a system's spatial order and most phase transitions, like those responsible for ferromagnetism for instance, cannot occur. But there is a particular type of phase transition, involving the pairing of vortices, that does exist in two dimensions. First predicted 30 years ago by Berezinskii, Kosterlitz and Thouless, the ‘BKT transition’ has now been observed directly for the first time in a planar gas of ultracold rubidium atoms.
Any state of matter is classified according to its order, and the type of order that a physical system can possess is profoundly affected by its dimensionality. Conventional long-range order, as in a ferromagnet or a crystal, is common in three-dimensional systems at low temperature. However, in two-dimensional systems with a continuous symmetry, true long-range order is destroyed by thermal fluctuations at any finite temperature
1
,
2
. Consequently, for the case of identical bosons, a uniform two-dimensional fluid cannot undergo Bose–Einstein condensation, in contrast to the three-dimensional case. However, the two-dimensional system can form a ‘quasi-condensate’ and become superfluid below a finite critical temperature. The Berezinskii–Kosterlitz–Thouless (BKT) theory
3
,
4
associates this phase transition with the emergence of a topological order, resulting from the pairing of vortices with opposite circulation. Above the critical temperature, proliferation of unbound vortices is expected. Here we report the observation of a BKT-type crossover in a trapped quantum degenerate gas of rubidium atoms. Using a matter wave heterodyning technique, we observe both the long-wavelength fluctuations of the quasi-condensate phase and the free vortices. At low temperatures, the gas is quasi-coherent on the length scale set by the system size. As the temperature is increased, the loss of long-range coherence coincides with the onset of proliferation of free vortices. Our results provide direct experimental evidence for the microscopic mechanism underlying the BKT theory, and raise new questions regarding coherence and superfluidity in mesoscopic systems.
Journal Article
Hydrogen Sensing Mechanism of WS2 Gas Sensors Analyzed with DFT and NAP-XPS
by
Villar-Garcia, Ignacio J.
,
Minezaki, Tomoya
,
Alagh, Aanchal
in
2D materials
,
Chemical vapor deposition
,
Clean technology
2023
Nanostructured tungsten disulfide (WS2) is one of the most promising candidates for being used as active nanomaterial in chemiresistive gas sensors, as it responds to hydrogen gas at room temperature. This study analyzes the hydrogen sensing mechanism of a nanostructured WS2 layer using near-ambient-pressure X-ray photoelectron spectroscopy (NAP-XPS) and density functional theory (DFT). The W 4f and S 2p NAP-XPS spectra suggest that hydrogen makes physisorption on the WS2 active surface at room temperature and chemisorption on tungsten atoms at temperatures above 150 °C. DFT calculations show that a hydrogen molecule physically adsorbs on the defect-free WS2 monolayer, while it splits and makes chemical bonds with the nearest tungsten atoms on the sulfur point defect. The hydrogen adsorption on the sulfur defect causes a large charge transfer from the WS2 monolayer to the adsorbed hydrogen. In addition, it decreases the intensity of the in-gap state, which is generated by the sulfur point defect. Furthermore, the calculations explain the increase in the resistance of the gas sensor when hydrogen interacts with the WS2 active layer.
Journal Article
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
by
Kirkpatrick, Carl MJ
,
Paterson, David L
,
Lipman, Jeffrey
in
Adult
,
Aged
,
Anti-Bacterial Agents - administration & dosage
2015
Introduction
The aim of this study was to explore the impact of augmented creatinine clearance and differing minimum inhibitory concentrations (MIC) on piperacillin pharmacokinetic/pharmacodynamic (PK/PD) target attainment (time above MIC (
f
T
>MIC
)) in critically ill patients with sepsis receiving intermittent dosing.
Methods
To be eligible for enrolment, critically ill patients with sepsis had to be receiving piperacillin-tazobactam 4.5 g intravenously (IV) by intermittent infusion every 6 hours for presumed or confirmed nosocomial infection without significant renal impairment (defined by a plasma creatinine concentration greater than 171 μmol/L or the need for renal replacement therapy). Over a single dosing interval, blood samples were drawn to determine unbound plasma piperacillin concentrations. Renal function was assessed by measuring creatinine clearance (CL
CR
). A population PK model was constructed, and the probability of target attainment (PTA) for 50% and 100%
f
T
>MIC
was calculated for varying MIC and CL
CR
values.
Results
In total, 48 patients provided data. Increasing CL
CR
values were associated with lower trough plasma piperacillin concentrations (
P
< 0.01), such that with an MIC of 16 mg/L, 100%
f
T
>MIC
would be achieved in only one-third (
n
= 16) of patients. Mean piperacillin clearance was approximately 1.5-fold higher than in healthy volunteers and correlated with CL
CR
(
r
= 0.58,
P
< 0.01). A reduced PTA for all MIC values, when targeting either 50% or 100%
f
T
>MIC
, was noted with increasing CL
CR
measures.
Conclusions
Standard intermittent piperacillin-tazobactam dosing is unlikely to achieve optimal piperacillin exposures in a significant proportion of critically ill patients with sepsis, owing to elevated drug clearance. These data suggest that CL
CR
can be employed as a useful tool to determine whether piperacillin PK/PD target attainment is likely with a range of MIC values.
Journal Article
The feasibility of using mouthpiece ventilation in the intensive care unit for post-extubation breathing support after acute tetraplegia
by
Kruger, Peter S
,
Wadsworth, Brooke M
,
Hukins, Craig A
in
Extubation
,
Feasibility studies
,
Feedback
2023
Study designA prospective cohort of patients with acute tetraplegia.ObjectivesThis study aimed to determine the feasibility of using mouthpiece ventilation (MPV) in the intensive care unit (ICU) for patients who are extubated after suffering an acute cervical spinal cord injury (CSCI).SettingICU, Princess Alexandra Hospital, Brisbane Australia.MethodsNew admissions to ICU in the 14 months between April 2017 and June 2018 with a CSCI who underwent intubation were assessed for inclusion. MPV was provided to consenting participants (who were deemed likely to be able to maintain ventilation on their own) at the time of extubation and was utilised in addition to standard care while participants were awake. MPV settings, usage, and support hours to educate and facilitate MPV were collected. Feedback from participants and clinical staff was gathered throughout the study. Pre- and post-extubation measures of forced vital capacity (FVC), the frequency of endotracheal suction of sputum, and gas exchange using ventilation-perfusion ratios were recorded along with the incidence of reintubation.ResultsFourteen participated in utilising MPV with 16 episodes of extubation. The average time per participant to have MPV titrated and bedside data collected was 178 minutes. Data from 16 episodes of extubation have been included. Three of the 14 participants failed initial extubation. Feedback from participants and clinicians has been positive and constructive, enabling MPV settings to be adapted to the person with acute CSCI during this pilot study.ConclusionMPV is feasible to use post-extubation for people with CSCI in ICU. Pressure control mode MPV was deemed the most suitable for newly extubated acute CSCI patients. Intensive clinical support is required initially to provide education prior to MPV, and at the time of extubation for both patient and treating clinicians. Both report it to be a useful adjunct to ICU treatment.
Journal Article
3D Diatom–Designed and Selective Laser Melting (SLM) Manufactured Metallic Structures
2019
Diatom frustules, with their diverse three-dimensional regular silica structures and nano- to micrometer dimensions, represent perfect model systems for biomimetic fabrication of materials and devices. The structure of a frustule of the diatom
Didymosphenia geminata
was nondestructively visualized using nano X-ray computed tomography (XCT) and transferred into a CAD file for the first time. Subsequently, this CAD file was used as the input for an engineered object, which was manufactured by applying an additive manufacturing technique (3D Selective Laser Melting, SLM) and using titanium powder. The self-similarity of the natural and the engineered objects was verified using nano and micro XCT. The biomimetic approach described in this paper is a proof-of-concept for future developments in the scaling-up of manufacturing based on special properties of microorganisms.
Journal Article
Continuation of Statin Therapy in Patients with Presumed Infection: A Randomized Controlled Trial
by
Kostner, Karam M.
,
Kruger, Peter S.
,
Joyce, Christopher J.
in
Aged
,
Aged, 80 and over
,
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
2011
Abstract
Rationale
In patients on prior statin therapy who are hospitalized for acute infections, current literature is unclear on whether statins should be continued during their hospitalization.
Objectives
To test the hypothesis that continuation of therapy with statins influences the inflammatory response to infection and that cessation may cause an inflammatory rebound.
Methods
Prospective randomized double-blind placebo-controlled trial of atorvastatin (20 mg) or matched placebo in 150 patients on preexisting statin therapy requiring hospitalization for infection.
Measurements and Main Results
The primary end point was progression of sepsis during hospitalization. At baseline, the rate of severe sepsis was 32% in both groups. Compared with baseline, the odds ratio for severe sepsis declined in both groups: 0.43 placebo and 0.5 statins (Day 3) versus 0.14 placebo and 0.12 statins (Day 14). The rate of decline of severe sepsis was similar between the groups (odds ratio 1.17 [0.56–2.47], P = 0.7 Day 3; 0.85 [0.21–3.34], P = 0.8 Day 14). IL-6 and C-reactive protein declined in both groups with no statistically significant difference (P = 0.7 and P = 0.2, respectively). An increase in cholesterol occurred in the placebo group (P < 0.0001). Most patients were not critically ill. Hospital mortality was 6.6%, with no difference between the groups (6 [8%] of 75 statin group; 4 [5.3%] of 75 placebo group; P = 0.75).
Conclusions
This study does not support a beneficial role of continuing preexisting statin therapy on sepsis and inflammatory parameters. Cessation of established statin therapy was not associated with an inflammatory rebound.
Clinical trial registered at the Australian New Zealand Clinical Trials Registry (ACTRN 12605000756628).
Journal Article